Developer docs
API playgroundTry for free, no card

Search company profiles

American Gut

Full company profile

uuid0031ml8

Namestring
American Gut
Legal namestring
The Microsetta Initiative
Websiteurl
americangut.org
Company typeenum
Private
Founded yearstring
-
Descriptiontext

The Microsetta Initiative (formerly American Gut Project) is a citizen science microbiome research initiative hosted at UC San Diego and led by Dr. Rob Knight as Principal Investigator and Co-Founder. It enrolls members of the public globally who donate financially to receive a sample collection kit, return microbiome samples (gut, oral, skin, vaginal), and receive a personalized microbiome report. The core product is a research-grade data platform that aggregates thousands of participant samples across multiple countries and publishes findings in scientific journals, with data having appeared in over 85 publications to date. The initiative also distributes educational content such as the '30 Plants Per Week' gut-health program and maintains a multilingual web presence (English, Japanese, Spanish).

The business model blends consumer crowdfunding (one-time participant donations for kits and reports) with institutional sponsorship from the NIH (core), Danone, and Seerave. Distribution is entirely self-serve via the microsetta.ucsd.edu and microsetta-rest.ucsd.edu portals, with marketing concentrated on organic social channels (Instagram, Twitter, YouTube, LinkedIn, Facebook) and an email newsletter. The project does not sell software, APIs, or licenses commercially. As of February 17, 2026, the initiative paused new crowdfunded enrollment to enhance the participant experience, with kit returns required by March 15, 2026, and a planned reopening later in the year.

Short descriptiontext

The Microsetta Initiative (formerly American Gut) is a UC San Diego-affiliated citizen science project that collects microbiome samples from crowdfunded participants worldwide and publishes research on the human microbiome's role in health and disease.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersLa Jolla, United States
HQ citystring
La Jolla
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
citizen science microbiome, gut microbiome research, microbiome sample analysis, microbiome research project, crowdfunded research study
Industry3 codes
PRIMARYHLAAAFAH
Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal)
SECONDARYHLAAAFAI
Microbiome Analytics, Sequencing & Bioinformatics Platforms
SECONDARYHLAAAFAC
Consortia & Defined Microbial Community Therapeutics
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Citizen Science Microbiome Research
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Crowdfunded Participant Donations
TypeOne Time License
Description

The project generates revenue through crowdfunding where participants donate to join the study and receive a personalized microbiome report in return. Enrollment closed for new crowdfunded participants effective February 17, 2026.

microsetta.ucsd.edu
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

The Microsetta Initiative (formerly American Gut Project) is the world's largest citizen science microbiome project. Individuals donate microbiome samples (gut, oral, skin, vaginal) and contribute to a crowdfunding-based research study; in return, participants receive personalized microbiome reports. The project generates large-scale microbiome datasets that have been published in over 85 scientific journals and help advance understanding of microbial roles in health and disease, including inflammatory bowel disease and obesity.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Data published in over 85 scientific journals
+1 more record
Product overview1 text field

The Microsetta Initiative (formerly American Gut Project) operates as a single unified citizen science platform focused on microbiome research. The core offering is a sample collection kit program where participants donate samples, and in return receive personalized microbiome reports. The project functions as both a research study and a public engagement initiative, with data published in over 85 scientific journals. The initiative also includes educational components such as the '30 Plants Per Week' program focused on gut health awareness.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Viome offers direct-to-consumer gut and oral microbiome testing with personalized nutrition recommendations, paralleling American Gut's participant-paid model and microbiome analysis focus. Both target health-conscious consumers seeking personalized insights from stool/saliva samples.

2Second Genome
TypeEmerging player
Description

Second Genome applies microbiome science to drug discovery and therapeutic development, leveraging large microbiome datasets. Comparable in that both organizations sit at the intersection of citizen/clinical microbiome data and downstream translational research.

TypeEmerging player
Description

Arivale offered multi-omic (genomic, microbiome, metabolomic) consumer coaching services integrating large datasets into personalized wellness plans. While it ceased operations, its model is conceptually comparable to American Gut's combination of participant data generation and personalized reporting.

TypeEmerging player
Description

BIOHM Health offers consumer microbiome testing with a focus on gut-and-oral fungal and bacterial communities, addressing total microbiome balance. It overlaps with American Gut's multi-body-site focus and consumer testing model.

TypeDirect peer
Description

Atlas Biomed offers direct-to-consumer gut microbiome and DNA testing with personalized health and nutrition reports. It mirrors American Gut's citizen-participant sample collection model combined with personalized microbiome reporting.

TypeDirect peer
Description

ZOE runs large-scale citizen-science-style cohort studies combined with consumer microbiome and metabolic testing to deliver personalized nutrition scores. It is comparable to American Gut in combining cohort-scale data generation with consumer-facing personalized reporting.

TypeDirect peer
Description

DayTwo provides microbiome-based personalized nutrition recommendations, leveraging large gut microbiome datasets to predict glycemic response. It competes with American Gut's value proposition of turning microbiome data into actionable health insights.

TypeBroad incumbent
Description

Human Longevity Inc. integrates genomics, microbiome, and other -omics into premium health-focused offerings. While broader in scope, it overlaps with American Gut in applying large-scale -omics data to personalized health insights.

TypeOthers
Description

Psomagen provides sequencing and bioinformatics services including microbiome sequencing for researchers and consumer testing brands. It is an ecosystem enabler — a sequencing infrastructure provider that supports microbiome projects analogous to American Gut.

TypeDirect peer
Description

Sun Genomics provides personalized gut microbiome testing and probiotic formulations based on individual sample analysis. Comparable to American Gut in collecting consumer samples for sequencing and returning personalized microbiome insights.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

American Gut

Citizen Science Microbiome Researchamericangut.org

The Microsetta Initiative (formerly American Gut) is a UC San Diego-affiliated citizen science project that collects microbiome samples from crowdfunded participants worldwide and publishes research on the human microbiome's role in health and disease.

What American Gut does

The Microsetta Initiative (formerly American Gut Project) is a citizen science microbiome research initiative hosted at UC San Diego and led by Dr. Rob Knight as Principal Investigator and Co-Founder. It enrolls members of the public globally who donate financially to receive a sample collection kit, return microbiome samples (gut, oral, skin, vaginal), and receive a personalized microbiome report. The core product is a research-grade data platform that aggregates thousands of participant samples across multiple countries and publishes findings in scientific journals, with data having appeared in over 85 publications to date. The initiative also distributes educational content such as the '30 Plants Per Week' gut-health program and maintains a multilingual web presence (English, Japanese, Spanish).

The business model blends consumer crowdfunding (one-time participant donations for kits and reports) with institutional sponsorship from the NIH (core), Danone, and Seerave. Distribution is entirely self-serve via the microsetta.ucsd.edu and microsetta-rest.ucsd.edu portals, with marketing concentrated on organic social channels (Instagram, Twitter, YouTube, LinkedIn, Facebook) and an email newsletter. The project does not sell software, APIs, or licenses commercially. As of February 17, 2026, the initiative paused new crowdfunded enrollment to enhance the participant experience, with kit returns required by March 15, 2026, and a planned reopening later in the year.

American Gut firmographics

Firmographics
Name
American Gut
Legal name
The Microsetta Initiative
Website
https://americangut.org
Company type
Private
Operating status
Operating
Short description
The Microsetta Initiative (formerly American Gut) is a UC San Diego-affiliated citizen science project that collects microbiome samples from crowdfunded participants worldwide and publishes research on the human microbiome's role in health and disease.
Ownership category
akta.pro rank

American Gut industry classification

Industry
Product category
Citizen Science Microbiome Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAAAFAH
Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal)
SECONDARYHLAAAFAI
Microbiome Analytics, Sequencing & Bioinformatics Platforms
SECONDARYHLAAAFAC
Consortia & Defined Microbial Community Therapeutics

Keywords

  • Citizen science microbiome
  • Gut microbiome research
  • Microbiome sample analysis
  • Microbiome research project
  • Crowdfunded research study

Where American Gut is headquartered

Location

Headquarters

HQ city
La Jolla
HQ country
United States
HQ region
North America

Offices1 record

Markets served

American Gut business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Crowdfunded Participant Donations: The project generates revenue through crowdfunding where participants donate to join the study and receive a personalized microbiome report in return. Enrollment closed for new crowdfunded participants effective February 17, 2026.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

American Gut product offering

Product offering

Core offering

The Microsetta Initiative (formerly American Gut Project) is the world's largest citizen science microbiome project. Individuals donate microbiome samples (gut, oral, skin, vaginal) and contribute to a crowdfunding-based research study; in return, participants receive personalized microbiome reports. The project generates large-scale microbiome datasets that have been published in over 85 scientific journals and help advance understanding of microbial roles in health and disease, including inflammatory bowel disease and obesity.

Product overview

The Microsetta Initiative (formerly American Gut Project) operates as a single unified citizen science platform focused on microbiome research. The core offering is a sample collection kit program where participants donate samples, and in return receive personalized microbiome reports. The project functions as both a research study and a public engagement initiative, with data published in over 85 scientific journals. The initiative also includes educational components such as the '30 Plants Per Week' program focused on gut health awareness.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • Data published in over 85 scientific journals
  • +1 more outcomes

Companies that use American Gut

Customer profile

Segments1 record

Ideal customer profiles2 records

American Gut technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

American Gut partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

American Gut competitors and assessment

Company assessment

Direct peers

  • Viome: Viome offers direct-to-consumer gut and oral microbiome testing with personalized nutrition recommendations, paralleling American Gut's participant-paid model and microbiome analysis focus. Both target health-conscious consumers seeking personalized insights from stool/saliva samples.
  • Atlas Biomed: Atlas Biomed offers direct-to-consumer gut microbiome and DNA testing with personalized health and nutrition reports. It mirrors American Gut's citizen-participant sample collection model combined with personalized microbiome reporting.
  • ZOE: ZOE runs large-scale citizen-science-style cohort studies combined with consumer microbiome and metabolic testing to deliver personalized nutrition scores. It is comparable to American Gut in combining cohort-scale data generation with consumer-facing personalized reporting.
  • DayTwo: DayTwo provides microbiome-based personalized nutrition recommendations, leveraging large gut microbiome datasets to predict glycemic response. It competes with American Gut's value proposition of turning microbiome data into actionable health insights.
  • Sun Genomics (formerly Thryve): Sun Genomics provides personalized gut microbiome testing and probiotic formulations based on individual sample analysis. Comparable to American Gut in collecting consumer samples for sequencing and returning personalized microbiome insights.

Emerging players

  • Second Genome: Second Genome applies microbiome science to drug discovery and therapeutic development, leveraging large microbiome datasets. Comparable in that both organizations sit at the intersection of citizen/clinical microbiome data and downstream translational research.
  • Arivale: Arivale offered multi-omic (genomic, microbiome, metabolomic) consumer coaching services integrating large datasets into personalized wellness plans. While it ceased operations, its model is conceptually comparable to American Gut's combination of participant data generation and personalized reporting.
  • BIOHM Health: BIOHM Health offers consumer microbiome testing with a focus on gut-and-oral fungal and bacterial communities, addressing total microbiome balance. It overlaps with American Gut's multi-body-site focus and consumer testing model.

Broad incumbents

  • Human Longevity Inc. Human Longevity Inc. integrates genomics, microbiome, and other -omics into premium health-focused offerings. While broader in scope, it overlaps with American Gut in applying large-scale -omics data to personalized health insights.

Others

  • Psomagen: Psomagen provides sequencing and bioinformatics services including microbiome sequencing for researchers and consumer testing brands. It is an ecosystem enabler — a sequencing infrastructure provider that supports microbiome projects analogous to American Gut.

Market position

Strengths5 records

Weaknesses3 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

American Gut social profiles

Digital presence

American Gut financial estimates

Financial estimate

Revenue estimate

Valuation estimate

American Gut leadership team

Management profile

Number of profiles

Profiles1 record

American Gut funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

American Gut M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about American Gut

What does American Gut do?

The Microsetta Initiative (formerly American Gut Project) is the world's largest citizen science microbiome project. Individuals donate microbiome samples (gut, oral, skin, vaginal) and contribute to a crowdfunding-based research study; in return, participants receive personalized microbiome reports. The project generates large-scale microbiome datasets that have been published in over 85 scientific journals and help advance understanding of microbial roles in health and disease, including inflammatory bowel disease and obesity.

Is American Gut a public or private company?

American Gut is a private company. It is classified as unknown and is currently operating.

When was American Gut founded?

American Gut was founded in -1.

Where is American Gut based?

American Gut is headquartered in La Jolla, United States, in the North America region.

How does American Gut make money?

One revenue line is on record: crowdfunded Participant Donations.

Who are American Gut's main competitors?

Direct peers on record are Viome, Atlas Biomed, ZOE, DayTwo and Sun Genomics (formerly Thryve). Emerging players are Second Genome, Arivale and BIOHM Health. Human Longevity Inc. is listed as a broad incumbent. Psomagen is listed as an others.

Does American Gut have an API?

No public API is recorded for American Gut.

What industry is American Gut in?

American Gut's product category is Citizen Science Microbiome Research. Its primary akta.pro industry code is HLAAAFAH, Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal), with a secondary code of HLAAAFAI, Microbiome Analytics, Sequencing & Bioinformatics Platforms. Its NAICS code is 541714 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals